This free eBook goes over the 10 slides every startup pitch deck has to include, based on what we learned from analyzing 500+ pitch decks, including those from Airbnb, Uber and Spotify.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →
Fyodor Bio effectively frames the problem by using large, impactful numbers like 212 million cases and half a million deaths annually to establish the massive scale of the malaria crisis. They connect this global health issue to the specific pain point of slow, invasive traditional testing methods, creating a clear need for their solution. This approach immediately signals a significant, urgent market to investors.
Our Tip: Present the problem using both large-scale market data and a relatable human-level pain point to create a compelling narrative that resonates logically and emotionally with investors.
The pitch clearly presents the Urine Malaria Test (UMT) as a simple, one-step solution, directly addressing the pain points of traditional blood tests. They define their value proposition around three core pillars: it is non-invasive, fast (25 minutes), and requires no special equipment. This clear articulation of benefits, rather than just features, makes the innovation's real-world impact immediately understandable.
Our Tip: Clearly articulate your value proposition by focusing on three to four key benefits that directly solve the previously stated problem, making your differentiation easy to remember.
The deck validates the market opportunity by citing a specific market size of $789 million in 2022 and a projected growth rate of 4.5%. By identifying the target market as healthcare providers in high-impact regions like Africa and Southeast Asia, they demonstrate a focused initial strategy. This combination of macro data and a specific target segment shows investors both the size of the prize and a credible plan to start capturing it.
Our Tip: Combine top-down market sizing with a bottom-up analysis of your specific target segment to show investors you understand the total addressable market and have a realistic entry point.
Fyodor Bio uses regulatory approvals in Nigeria and Liberia as powerful social proof, which is a critical form of validation in the highly regulated medical device industry. This traction serves as a major de-risking event for investors, proving the product has met stringent government standards. Mentioning active partnership interest further signals market pull and commercial viability before significant revenue.
Our Tip: Showcase traction that directly de-risks the biggest questions in your business, such as regulatory approval for deep tech or early revenue for SaaS.
Fyodor Bio masterfully translates a complex medical problem and scientific solution into an easily digestible story for investors. They connect a massive market to a clear pain point and present a simple, three-benefit solution that is impossible to misunderstand. Distill your entire business into a clear, linear narrative that an outsider can grasp in seconds, always prioritizing benefits over features.
This deck consistently uses concrete validation to build credibility and de-risk the investment at every single stage. Instead of relying on future projections, they use specific market data and critical traction like regulatory approvals to prove their viability today. Focus your pitch on providing tangible evidence that directly answers the biggest investor questions in your industry, turning assumptions into certainties.
